Peptide YY stimulates the expression of apolipoprotein A-IV gene in Caco-2 intestinal cells

Proceedings of the Society for Experimental Biology and Medicine

Volumn 223, Issue 3, 2000, Pages 270-275

  Sonoyama, Kei ^a   Suzuki, Keiko ^a   Kasai, Takanori ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A4; PEPTIDE YY;

ANIMAL CELL; ARTICLE; CELL STRAIN CACO 2; FEEDING BEHAVIOR; GENE EXPRESSION; HYPOTHESIS; INTESTINE CELL; LIPOPROTEIN METABOLISM; NONHUMAN; OLIGONUCLEOTIDE PROBE; PROTEIN SYNTHESIS; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; STOMACH FUNCTION; WESTERN BLOTTING;

EID: 0034075388     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.2000.22338.x     Document Type: Article

References (37)

1. Elshourbagy NA, Boguski MS, Liao WSL, Jefferson LS, Gordon JI, Taylor JM. Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin. Proc Natl Acad Sci U S A 82:8242-8246, 1985.
2. Chen CH, Albers JJ. Activation of lecithin: Cholesterol acyltransferase by apolipoproteins E-2, E-3, and A-IV isolated from human plasma. Biochim Biophys Acta 836:279-285, 1985.
3. Dvorin E, Gorder NL, Benson DM, Gotto AM Jr. Apolipoprotein A-IV: A determinant for binding and uptake of high density lipoproteins by rat hepatocytes. J Biol Chem 261:15714-15728, 1986.
4. Stein O, Stein Y, Lefevre M, Roheim PS. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim Biophys Acta 878:7-13, 1986.
5. Steinmetz A, Utermann G. Activation of lecithin: Cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem 260:2258-2264, 1985.
6. Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart JC, Ailhaud G. Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem 265:7859-7863, 1990.
7. Fujimoto K, Cardelli JA, Tso P. Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am J Physiol 262:G1002-G1006, 1992.
8. Fujimoto K, Fukagawa K, Sakata T, Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest 91:1830-1833, 1993.
9. Okumura T, Fukagawa K, Tso P, Taylor IL, Pappas TN. Intracisternal injection of apolipoprotein A-IV inhibits gastric secretion in pylorusligated conscious rats. Gastroenterology 107:1861-1864, 1994.
10. Okumura T, Fukagawa K, Tso P, Taylor IL, Pappas TN, Uehara A, Kohgo Y. Delayed gastric emptying by central apolipoprotein A-IV in rats. Gastroenterology 108:A996, 1995.
11. Sonoyama K, Kiriyama S, Niki R. Adaptive response of apolipoprotein A-I and A-IV mRNA in residual ileum after massive small bowel resection in rats. J Nutr Sci Vitaminol 41:253-264, 1995.
12. Sonoyama K, Nakamura Y, Kiriyama S, Niki R. Upregulation of apolipoprotein A-IV gene expression in residual ileum after massive small bowel resection requires the biliary secretion in rats. Proc Soc Exp Biol Med 211:273-280, 1996.
13. Sonoyama K, Aoyama Y. Different responses of apolipoprotein A-I, A-IV, and B gene expression during intestinal adaptation to a massive small bowel resection in rats. Biosci Biotechnol Biochem 61:1810-1813, 1997.
14. Ali-Rachedi A, Varndell IM, Adrian TE, Gapp DA, Van Noorden S, Bloom SR, Polak JM. Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas. Histochemistry 80:487-491, 1984.
15. Bottcher G, Sjolund K, Ekblad E, Hakanson R, Schwartz TW, Sundler F. Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept 8:261-266, 1984.
16. Savage AP, Gornacz GE, Adrian TE, Ghatei MA, Goodlad RA, Wright NA, Bloom SR. Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response? Gut 26:1353-1358, 1985.
17. Taylor RG, Beveridge DJ, Fuller PJ. Expression of ileal glucagon and peptide tyrosine-tyrosine genes: Response to inhibition of polyamine synthesis in the presence of massive small-bowel resection. Biochem J 286:737-741, 1992.
18. Fuller PJ, Beveridge DJ, Taylor RG. Ileal proglucagon gene expression in the rat: Characterization in intestinal adaptation using in situ hybridization. Gastroenterology 104:459-466, 1993.
19. Gordon JI. Intestinal epithelial differentiation: New insights from chimeric and transgenic mice. J Cell Biol 108:1187-1194, 1989.
20. Levy E, Mehran M, Seidman E. Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion. FASEB J 9:626-635, 1995.
21. Davidson NO, Magun AM, Brasitus TA, Glickman RM. Intestinal apolipoprotein A-I and B-48 metabolism: Effects of sustained alterations in dietary triglyceride and mucosal cholesterol flux. J Lipid Res 28:388-402, 1987.
22. Fidge NH. The redistribution and metabolism of iodinated apolipoprotein A-IV in rats. Biochim Biophys Acta 619:129-141, 1980.
23. Hayashi H, Fujimoto K, Cardelli JA, Nutting DF, Bergstedt S, Tso P. Fat feeding increases size, but not number, of chylomicrons produced by small intestine. Am J Physiol 259:G709-G719, 1990.
24. Weinberg RB, Dantzker C, Patton CS. Sensitivity of serum apolipoprotein A-IV levels to changes in dietary fat content. Gastroenterology 98:17-24, 1990.
25. Karathanasis SK. Apolipoprotein multigene family: Tandem organization of human apolipoprotein AI, CIII, and AIV genes. Proc Natl Acad Sci U S A 82:6374-6378, 1985.
26. Pappas TN, Debas HT, Goto Y, Taylor IL. Peptide YY inhibits meal-stimulated pancreatic and gastric secretion. Am J Physiol 248: G118-G123, 1985.
27. Aponte GW, Fink AS, Meyer JH, Tatemoto K, Taylor IL. Regional distribution and release of peptide YY with fatty acids of different chain length. Am J Physiol 249:G745-G750, 1985.
28. Aponte GW, Park K, Hess R, Garcia R, Taylor IL. Meal-induced peptide tyrosine tyrosine inhibition of pancreatic secretion in the rat. FASEB J 3:1949-1955, 1989.
29. Gordon JI, Smith DP, Alpers DH, Strauss AW. Cloning of a complementary deoxyribonucleic acid encoding a portion of rat intestinal preapolipoprotein AIV messenger ribonucleic acid. Biochemistry 21:5424-5431, 1982.
30. Halldén G, Aponte GW. Evidence for a role of the gut hormone PYY in the regulation of intestinal fatty acid-binding protein transcripts in differentiated subpopulations of intestinal epithelial cell hybrids. J Biol Chem 272:12591-12600, 1997.
31. Gordon JI, Elshourbagy N, Lowe JB, Liao WS, Alpers DH, Taylor JM. Tissue-specific expression and developmental regulation of two genes coding for rat fatty acid binding proteins. J Biol Chem 260:1995-1998, 1985.
32. Hsu KT, Storch J. Fatty acid transfer from liver and intestinal fatty acid binding proteins to membranes occurs by different mechanisms. J Biol Chem 271:13317-13323, 1996.
33. Bass NM. The cellular fatty acid binding proteins: Aspects of structure, regulation, and function. Int Rev Cytol 111:143-184, 1988.
34. Rubin DC, Swietlicki EA, Wang JL, Dodson BD, Levin MS. Enterocytic gene expression in intestinal adaptation: Evidence for a specific cellular response. Am J Physiol 270:G143-G152, 1996.
35. Blomqvist AG, Herzog H. Y-receptor subtypes: How many more? Trends Neurosci 20:294-298, 1997.
36. Kalogeris TJ, Qin X, Chey WY, Tso P. PYY stimulates synthesis and secretion of intestinal apolipoprotein A-IV without affecting mRNA expression. Am J Physiol 275:G668-G674, 1998.
37. Chen CH, Rogers RC. Central inhibitory action of peptide YY on gastric motility in rats. Am J Physiol 269:R787-R792, 1995.